Prominent Players - Smart Inhalers Industry

A smart inhaler is a medical equipment that connects to a smartphone app, for example, via Bluetooth. These gadgets use sensor technology to collect data regarding the time and date of use, as well as the patient's location at each use. The global smart inhalers market is expanding rapidly as the prevalence of respiratory illnesses rises and the world's geriatric (aged) population grows. Furthermore, rising demand for/adoption of smart inhalers or respiratory inhalers, as well as the breakout of COVID-19, are projected to drive market expansion. However, concerns such as data misuse and breach of data privacy, as well as a lack of knowledge and the expensive cost of smart inhalers, are projected to stymie market expansion.

The global Smart Inhalers Market was valued at US$ 236.1 Mn in 2022 and is forecast to reach a value of US$ 9,357.4 Mn by 2030 at a CAGR of 58.40% between 2023 and 2030.

Key Competitors in the Smart Inhalers Industry:

1. Adherium Limited

Adherium Limited  founded in 2001 and its headquarters New Zealand. The company operates in 100 countries. Adherium Limited is an international Respiratory eHealth company focused on patient adherence, remote monitoring & data management solutions for patients,

2. AstraZeneca

AstraZeneca founded in 1999, and its Headquarters located in Cambridge, United Kingdom. The company operates in 15 nations.  In 2022 AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers.

3. Boehringer Ingelheim

Boehringer Ingelheim was launch in 1885 and it’s headquarter located Ingelheim am Rhein, Germany.it operate over 13 country. Boehringer Ingelheim (BI) is to work with Qualcomm to 'digitally has bought its own smart inhaler company, Gecko Health Innovations

4. Cohero Health

Cohero Health  was launch in 2012 and it’s headquarter, New York, United States..it operate over 18 country.In 2018 Cohero Health have launched the first market-ready, intuitive, fully-embedded and connected metered dose inhaler (eMDI).

5. Novartis

Novartis  was founded 1996 with its headquarters in Basel, Switzerland. With businesses in over 140 countries. Novartis and Qualcomm are expanding their partnership in order to bring smart technology to next-generation inhalers.

6. ResMed

ResMed .was launch in 1989. And its headquarter San Diego, California, United States. It operate over 140 country.In ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions.

*Definition-

A smart inhaler is a medical device that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.